Aerpio Pharmaceuticals, Inc. (ARPO) financial statements (2020 and earlier)

Company profile

Business Address 9987 CARVER ROAD
CINCINNATI, OH 45242
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3963200000
Cash and cash equivalents3963200000
Prepaid expense010   0
Other current assets110    
Total current assets:4064210000
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment000    
Deposits noncurrent assets000    
Total noncurrent assets:000    
TOTAL ASSETS:4064210000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3540000
Accounts payable0110000
Accrued liabilities0100000
Employee-related liabilities121    
Interest and dividends payable   000 
Other undisclosed accounts payable and accrued liabilities221    
Debt0      
Due to related parties   000 
Other undisclosed current liabilities      0
Total current liabilities:3540000
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Total noncurrent liabilities:0      
Total liabilities:3540000
Stockholders' equity
Stockholders' equity attributable to parent, including:375917(0)(0)(0)(0)
Common stock0000000
Additional paid in capital1791781260000
Accumulated deficit(142)(119)(109)(0)(0)  
Other undisclosed stockholders' equity attributable to parent     (0)(0)
Total stockholders' equity:375917(0)(0)(0)(0)
TOTAL LIABILITIES AND EQUITY:4064210000

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit: 20     
Operating expenses(24)(31)(21)(0)(0)(0)(0)
Operating loss:(24)(11)(21)(0)(0)(0)(0)
Nonoperating income (expense)11(0)    
Interest and debt expense  (0)(0)(0)(0)(0)
Net loss:(23)(10)(21)(0)(0)(0)(0)
Other undisclosed net income attributable to parent  0    
Net loss attributable to parent:(23)(10)(21)(0)(0)(0)(0)
Preferred stock dividends and other adjustments  (1)    
Net loss available to common stockholders, diluted:(23)(10)(22)(0)(0)(0)(0)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(23)(10)(21)(0)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(23)(10)(21)(0)(0)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: